Skip to main content
. 2019 Mar 7;474(6):691–699. doi: 10.1007/s00428-019-02549-1

Fig. 2.

Fig. 2

Disease-specific survival of patients with pancreatic ductal adenocarcinoma, stratified by low, moderate, and high immune cell scores, determined in hotspots